IHS Chemical Week

World News and Views :: Top of the News

Bayer to acquire birth control firm Conceptus for $1.1 billion

1:11 AM MDT | April 29, 2013 | Natasha Alperowicz

Bayer HealthCare has signed a merger agreement with Conceptus (Mountain View; CA), the developer of the Essure procedure—a leading nonsurgical, permanent birth-control method, Bayer announced today. The move aims to broaden Bayer’s portfolio in the field of contraception. Bayer, following the acquisition, will be able to offer a complete range of short-term, long-term, and permanent contraceptive choices for women, the company says.     Bayer will launch a public tender offer to acquire all shares in Conceptus within the next...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa